R&Dplatform

联系我们

国际针灸合作委员会关于变更办公地址的通知

中国民间中医医药研究开发协会国际针灸合作委员会

办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,

同时为方便大家联系,固定电话已经变更

新号码010—58562339。特此通知。

地址:北京西城区西直门南小街国英园一号楼824室

邮编:100035

电话:010-58562339

传真:010-58562339

邮箱:cngjzj@163.com

网站(点击网址直接链接↓):http://www.cngjzj.com/

博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj

交通路线图 (点击观看大图)

到西城区西直门南小街国英园一号楼行驶路线

机场线路1

从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:

1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

机场线路2

从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。

附近公交地铁:

公交官园站:107路,运通106路

公交西直门南:387路,44路,800内环,816路,820内环,845路

地铁车公庄:地铁二号线

地铁西直门:地铁二号线

公交车公庄东:107路,118路,701路

公交车公庄北:209路,375路,392路

您现在的位置是: 首页 >> R&Dplatform >> R&Dplatform

Traditional Chinese medicine against cancer of single diseases have a new train of thought

2016年09月02日

复制链接 打印 大 中 小

<




Traditional Chinese medicine against cancer of single diseases have a new train of thought

Time: 2016-09-02

Source: China's traditional Chinese medicine

Author: among the Zhang Weijing


Report from our correspondent (reporter among the correspondent Zhang Weijing), reporters learned that the shijiazhuang city hospital Zhang Shishun name old doctor of traditional Chinese medicine studio academic leaders, the third batch of experience, the fourth batch of national famous old Chinese medicine academic inheritance work guidance teacher, presided over the first name Zhang Shishun director doctor of traditional Chinese medicine in hebei province to carry out the \"three treatment based on differentiation\" treatment of advanced lung cancer clinical research, has been through the transformation of scientific and technological achievements in hebei province service center of recognition of the organization.

Shijiazhuang city science and technology and intellectual property office of the people invited from China academy of traditional Chinese medicine, China Chinese acad med sci cancer hospital, hebei medical university, the Chinese medicine academy of sciences and other scientific research and medical units in hebei province seven experts appraisal committee, and the results agreed that the study design is reasonable, reliable data, reached similar study leading domestic level. The research for Chinese medicine treatment of cancer drug research of single diseases not only provides a new train of thought, and it is the treatment of traditional Chinese medicine tumor model of a kind of innovation, and promote the development of TCM. The study by scientific and technological achievements certificate issued by the department of hebei province.

\"Three treatment based on differentiation\" theory is the name old doctor of traditional Chinese medicine Zhang Shishun summarized his 54 years experience in treatment of tumor and the formation of the new theory of TCM anticancer. The so-called \"three treatment based on differentiation\", is the syndrome differentiation and treatment, pathological differentiation and disease differentiation. Zhang Shishun thinks, syndrome differentiation and treatment is the foundation of TCM theory, but as the complexity of disease cancer pathological mechanism is not the same, to be precise treatment, will be on the basis of syndrome differentiation and distinguishes the pathological differentiation; Even if the same cancer pathological mechanism at the same time, due to the cancer cells in different parts, and will show the different cancer, so to be more precise treatment, but also in the syndrome differentiation of traditional Chinese medicine, distinguishes the pathological differentiation, on the basis of further distinguishes the disease treatment, drug to cancer in parts. In traditional Chinese medicine based on syndrome differentiation theory systematically formed his new theory of \"three treatment based on differentiation\" anti-cancer, and guided by this theory, help more than hundreds of cases of cancer patients from all over the world to alleviate the symptoms and prolong the life, the longest survival time of patients with advanced lung cancer has been alive for 32 years.

The Zhang Shishun team submit the appraisal \"three treatment based on differentiation\" treatment of advanced lung cancer clinical research topic, is of Zhang Shishun between 2000 and 2015, under the guidance of the theory of three treatment based on differentiation therapy, 122 cases of lung cancer patients confirmed by pathological examination of the late review and summary. Compared with evidence-based medical observation shows that: in the \"three treatment based on differentiation\" under the guidance of the theory of using traditional Chinese medicine treatment of end-stage lung squamous carcinoma, adenocarcinoma and small cell carcinoma 1, 2, 3, 4, and 5 years survival rates compared to patients with the syndrome differentiation and treatment of simple group have significant differences, three treatment group effect better, patients with longer survival.

Appraisal committee believes that the traditional Chinese medicine cancer in the platform period, there are thought to have a way out, Zhang Shishun \"three treatment based on differentiation\" theory is a kind of innovation of TCM syndrome differentiation system.